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shown, that one reason for the difference might be a lowered
intracellular pH consequent to Donnan-related ion shifts that
result as intracellular fixed negative charges accumulate (4, 5).
The possiblity that the increased NTPs may act as allosteric cofactors much like P2-glycerate was also considered in order to
account for the lower blood oxygen affinity (3). However, Bunn
et aL (6) showed that the Mg2+-bound form of ATP does not
affect the oxygen affinity of hemoglobin.
In this communication, we apply 31P NMR to the study of
this hereditary erythrocyte enzyme deficiency to directly measure the intracellular pH and to further characterize the phosphate metabolites. The use of 31P NMR in the study of intracellular pH and metabolism in intact cells (7-9), perfused organs
(10-13), and even whole organisms (14) is now a well-established and often preferred method.
MATERIALS AND METHODS
Venous blood from healthy donors was drawn into heparin-containing tubes and washed several times in cold phosphate-buffered saline (pH 7.4). Blood was similarly drawn from the PND
individual.
Metabolic phosphates were extracted by the method of
Chen et aL (15) in which the erythrocytes are hemolyzed in
distilled water and protein is precipitated with trichloroacetic
acid. Removal of trichloroacetic acid was accomplished by using
tri-n-octylamine. Neutralized extracts were made 5 mM in
EDTA (pH 7.4). Metabolites, especially the unknown "CDP"
peak identified previously (3), were isolated by using HPLC
anion exchange columns (16) and desalted by gel filtration on
Sephadex G-15. Erythrocyte magnesium was determined by
C2H2 flame atomic absorption spectroscopy.
31P NMR spectra were obtained as described (11, 13, 17) at
60.7 MHz using a Nicolet NTC 150 wide-bore superconducting
spectrometer operating in the Fourier-transform mode. All
spectra were broad-band proton decoupled and measurements
were made at 250C. Spectra are presented in ppm relative to
phosphoric acid as an external standard. pH was determined
by measuring the difference (in ppm) between the 3-phosphate
peak of P2-glycerate and the a-P ATP peak of MgATP, which
serves as an internal standard insensitive to pH over the range
used. These shifts were compared with a simulated intraerythrocytic environment by titration of a hemolysate.
RESULTS AND DISCUSSION
Typical 60.7-MHz 31P NMR spectra of normal and PND erythrocytes are shown in Fig. 1. The normal spectrum is typical of

ABSTRACT The composition of phosphate metabolites and
the intracellular pH in erythrocytes from a patient with hereditary
pyrimidine-5'-nucleotidase deficiency were examined using 31P
NMR spectroscopy. Several resonances were identified in spectra
from intact cells and from extracts. The 2,3-bisphosphoglycerate
line intensities were normal but the NTP resonances were about
twice normal due to the presence of millimolar quantities of pyrimidine phosphates. Several intense resonances were also observed in the diphosphodiester region of the spectrum. One compound contributing to these lines has been identified as cytidine
diphosphocholine. The resonances of NTPs were in a position indicating that the additional triphosphates were also bound by
Mg2 . Direct measurement shows that there is a nearly proportional increase in total cell Mg2+ in the patient's cells, in agreement
with the interpretation of the spectra. The intracellular pH was
about 0.2 unit lower in the patient's erythrocytes. This lower pH
is due to the elevation in intracellular fixed negative charges and
the shift in permeable anions consequent to the Donnan equilibrium. We suggest that the lower intracellular pH may explain the
lower oxygen affinity of these cells in the presence of otherwise
normal 2,3-bisphosphoglycerate levels and the increased Mg2+
triphosphates level, because the Mg2+ form of NTPs is known not
to alter the oxygen affinity of hemoglobin under physiologic conditions. Furthermore, the lower intracellular pH can also explain
the abnormalities in glycolytic intermediates observed for these
cells.
In 1974, Valentine et al (1) described a hereditary hemolytic
anemia characterized by pronounced basophilic stippling with
a 3- to 6-fold increase in total erythrocyte nucleotides, predominantly of the pyrimidine type. They then found a pyrimidinespecific 5'-nucleotidase in erythrocytes and showed that the
activity of this enzyme was deficient in their patient's erythrocytes. Although it was initially assumed that pyrimidine nucleotide accumulation was derived from RNA degradation in
maturing erythrocytes, Harley et aL (2) showed that the salvage
pathway from uridine was the most likely major contributor to
accumulation of erythrocyte nucleotides in pyrimidine-5'-nu-

cleotidase deficiency (PND).
Torrance and Whittaker (3) have recently made a detailed
analysis of the composition of the nucleotide pool in this disease. They showed large increases in UTP and CTP levels with
little change in 2,3-bisphosphoglycerate (P2-glycerate) or ATP
concentrations. High levels of UDP-glucose and an unknown
cytidine diphosphate compound were noted, among other differences. They also showed that the oxygen affinity of blood
from these patients was lower than normal, despite the fact that
P2-glycerate levels were normal. It was suggested, although not
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intact washed erythrocytes (7, 18, 19). The strong P2-glycerate
and MgATP lines indicate that our cells were in excellent metabolic condition. The spectrum of PND erythrocytes is highly
unusual and reflects the large increase in pyrimidine phosphates (1-3). The P2-glycerate concentration is the same in the
normal and PND cells, in agreement with previous chemical
analyses (3).
The other peaks present in the spectrum ofthe patient's cells
are NTP-y, -a, and -[3 peaks (the Mg2+-bound form) and a collection of diphosphodiester peaks between about + 10 and + 13
ppm (see below). Comparison of the NTP-,8 peaks shows an
approximately 2-fold increase in the level of cellular triphosphates despite virtually identical P2-glycerate signals. The increase agrees with the chemical analysis of Torrance and Whittaker (3), who showed that patient and normal levels of ATP and
P2-glycerate were about the same while the UTP/CTP levels
equaled that of ATP in the patient. It is interesting that the
position ofthe NTP-[3peak is the same as control. This indicates
that the bulk ofthe extra NTPs are complexed with Mg2'. However, the patient erythrocytes would have to contain a higher
total Mg2+ to account for the spectrum. We have measured the
total erythrocyte Mg2+ levels directly and found, in agreement
with the NMR spectrum, that there was a compensatory increase in total Mg2+ (Table 1). Also, we have calculated the
concentrations of species present in normal and patient cells,
using our computer-assisted multiequilibria methods as described (17) in conjunction with previously published metabolite concentrations and stability constants (3, 20) and found that,
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FIG. 1. 31P NMR spectra at 60.7 MHz of normal (B) and PND (A)
erythrocytes. The cells were washed in Tris-buffered saline (pH 7.4).
Hematologic data from this subject showed a normal mean corpuscular
hemoglobin concentration (34.5 g/dl) with 8.3% reticulocytes and
polychromatophilia and basophilic stippling. Pyrimidine-5'-nucleotidase activity was 4.2 mol of uridine formed per hr per g of Hb (normal,
10.7-19.6). Three thousand pulses of 700 free-induction decays of 1.024
sec each at 25°C were accumulated for each spectrum. The spectra were
collected with broad-band proton decoupling. 2,3-DPG, P2-glycerate;
UDPG, uridine-P2-glycerate.

Table 1. Distribution of metabolites in normal and
PND erythrocytes
Normal, mM
PND, mM
Total Mg2+
2.3
3.2
Total ATP
1.2
1.06
Total CTP/UTP
1.05
Total NTP
1.2
2.11
Total P2-glycerate
4.06
5.08
Total HbO2
6.7
6.7
Free Mg2+
0.61
0.68
Free ATP
0.11
0.09
Free CTP/UTP
0.09
Free P2-glycerate
2.11
1.62
Free HbO2
4.4
4.2
MgATP
0.8
0.71
MgCTP/MgUTP
0.71
0.77
0.66
Mg2+ P2-glycerate
NTP-HbO2
0.17
0.28
P2-glycerate-HbO2
2.21
1.78
0.13
MgNTP-HbO2
0.24
Total Mg2" was measured by atomic absorption spectroscopy. Other
concentrations were calculated (17) based on total values given in ref
3. Conditions were pH 7.2, 370C, 20 mM NaCl/130 mM KCl.

70% of the total CTP/UTP exists in the Mg2+-bound form as
a consequence ofthe approximately equivalent increase in total
M2+.
Mg2~
The composition of the phosphate metabolites in PND cells
was investigated further by studying the spectra of trichloroacetic acid extracts from patient cells. The spectra show several
resolved resonances (Fig. 2). The NTP-,B region, now shifted
to the Mg2+-free position due to the presence of EDTA, shows
two sets of triplet peaks. They are assigned to NTP-(3 (purine)
and NTP-/3 (pyrimidine) compounds (21). The concentration of
purine triphosphates equals the concentration of pyrimidine
triphosphates (fable 1). Similar splittings are seen in the NTP'y resonances. The NTP-a resonances are more difficult to resolve in the extract spectra because they are shifted upfield due
to the absence of Mg2+ and now overlap peak 1 of the erythrocyte spectrum.
The positions of peaks, 1, 2, and 3 and the peaks in the region
of UDP-glucose are not changed with extraction. The concentrations of the compounds in the cell giving peaks 1, 2, and 3
are 1 to 2 mM (Fig. 1). Torrance and Whittaker (3) have found,
and we have confirmed, that an unknown cytidine diphosphate
compound is present at about the 1 mM level. However, they
were not able to completely identify the compound. We have
attempted to identify the compounds that may account for the
resonances in the diphosphodiester region. We have isolated
one compound in the unknown "cytidine diphosphate" peak of
Torrance and Whittaker (3) as described above and have collected 1H NMR spectra at 360 MHz using the spectrometer in
the Department of Chemistry at Lincoln. The spectrum (data
not shown) was the same as the model compound spectrum for
CDP-choline.
Although the 1H NMR measurements show that CDP-choline is present, this compound alone cannot account for the signals in the diphosphodiester region of the 31P NMR spectrum
of the patient's cells when model compounds are used for comparison. CDP-choline showed a 1:3:3:1 quartet with resonances at + 10.78, + 11.12, + 11.62, and + 11.98 ppm. The last
two peaks of CDP-choline would correspond to peak 3 and one
ofthe peaks in the region of Figs. 1 and 2 labeled UDP-glucose,
both with regard to chemical shift difference (0.35 ppm) and
peak intensities. The chemical shift difference between peaks
2 and 3 in the PND spectrum (0.49 ppm) is very similar to that
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FIG. 3. Dependence of the chemical shift differences (AA8) between the P2-glycerate 3-phosphate and the ATP a-phosphate resonances on measured pH for hemolysate (.) at physiologic ionic
strength and for control (A) and PND (o) erythrocytes. Spectral collection conditions were as in Fig. 1.
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FIG. 2. 31P NMR spectra of trichloroacetic acid extracts from PND
erythrocytes. The extracts were neutralized to pH 7.2. (A) Full-display
spectrum. (B) Expanded version of A from about +6 to +22 ppm. Fifteen thousand pulses of 700 free-induction decays of 1.024 sec each at
2500 were accumulated. The spectrum was collected with broad-band
proton decoupling. UDPG, uridine-P2-glycerate; pyr, pyrimidine; pur,
purine.

between the two central peaks of CDP-choline. Finally, the
difference between peaks 1 and 2 in the PND spectrum (0.35
ppm) is also very similar to that between the first two peaks of
CDP-choline. However, the peak-intensity ratios are not the
same. We believe that the presence of other compounds in this
region could explain this discrepancy. For example, CDP-ethanolamine has a single peak at 10.82 ppm, which, together with
the CDP-choline peak in that region, would give a higher intensity to peak 1 in the PND spectrum at about 10.78 ppm. Peak
2 of the PND spectrum at 11.0 ppm may gain added intensity
from the UDP-glucose peak at 11.0 ppm. Although it is at present difficult to positively identify all of the compounds contributing to the diphosphodiester region of the PND spectrum, we
suggest that CDP-choline, CDP-ethanolamine, and UDP-glucose are present.
One of the most useful recent applications of 31P NMR is in
measuring intracellular pH nondestructively (9, 14). The near
doubling of the total nucleotide phosphate pool in PND erythrocytes should lower the intracellular pH consequent to the
Donnan equilibrium. This phenomenon was shown several
years ago by Salhany et at (5) and Duhm (4), who correlated the
fall in intracellular pH level with a rise in P2-glycerate level.
Plots of measured (pH meter) pH values vs. the difference in
chemical shift (in ppm) between the P2-glycerate 3-phosphate
resonance and the NTP a-phosphate resonance for a hemolysate
and for intact control and PND erythrocytes are shown in Fig.
3. The hemolysate was titrated at physiologic ionic strength and
serves as a calibration curve. Qualitatively, the fact that the control and PND curves are displaced to the right of the hemolysate

line shows that intracellular pH is lower in control cells over this
range and even lower in PND cells. Quantitatively, we have
measured intracellular pH for both sets of cells at an extracellular pH of 7.4 and found that the pH of control cells was 7.2,
in agreement with other results (19), while the patient's cells
had a pH of 7.0, fully 0.2 unit below the normal value. These
pH values are accurate to ±0.03 pH unit based on an experimental error in measuring peak positions to within 0.01 ppm.
Furthermore, since the ionic strength of the hemolysate titration curve was physiological, comparison with intracellular ionic
strength should be valid.
Intracellular pH values as low as reported here have been
observed in a patient with autoimmune hemolytic anemia by
Lam et at (19), who also showed that the pH of erythrocytes
from patients with sickle cell disease was about 0.1 unit lower
than normal. It is difficult to know how the lower intracellular
pH found for PND erythrocytes might contribute to the hemolytic anemia. Several enzymes ofthe cell are sensitive to pH.
It is well known that a decrease in pH reduces overall flux
through the glycolytic pathway and so changes the levels of glycolytic intermediates. This has been studied by Minakami and
Yoshikawa (22), who showed little change in ATP but a substantial increase in glucose 6-phosphate. This increase will inhibit hexokinase. Fructose 6-phosphate is also elevated and a
crossover point occurs with phosphofructokinase, which is inhibited due to the effect of pH on the normally marked ATP
inhibition of this enzyme. A second crossover point occurs with
pyruvate kinase with an accumulation of pyruvate. Examination of the peaks in the sugar phosphate region of the 31P NMR
spectra of normal and PND cells shows a significant difference
in the intensity of the peak at -4.9 ppm (second peak from the
left). This peak is twice as intense in PND cells as in normal,
and its intensity and position in normal cells would be consistent
with glucose 6-phosphate. Although positive identification was
not made in our experiments, Paglia et at (23) have recently
reported a 2-fold increase in glucose 6-phosphate, consistent
with the tentative interpretation of the PND spectrum (Fig. 1).
Thus, we conclude that the 0.2-unit lowering of intracellular pH
of PND cells can explain the 2-fold increase in a sugar phosphate
tentatively identified as glucose 6-phosphate. The other peak
intensities are the same as control (the peak in the PND spectra

172

Biophysics:

Swanson et aL

between the 2- and 3-phosphate peaks of P2-glycerate is also
present in the control but is more evident in the PND spectrum
due to the pH shift in the resonances).
Besides alterations in glycolysis, the lower intracellular pH
will promote increased binding ofcytosol proteins to the membrane (24). Eisinger et al. (25) have recently shown increased
hemoglobin binding to or closer association with the membrane
of intact erythrocytes at an intracellular pH of 7.2-7.0. The extent to which additional hemoglobin or enzyme binding to band
3 protein alters membrane integrity remains an open and speculative area in need of further research.
The lower pH observed for PND cells very probably also
explains the lower oxygen affinity observed for PND blood (3).
We have calculated that a 0.2-unit lowering of intracellular pH
should decrease the oxygen affinity by about 25% over this pH
range. Torrance and Whittaker (3) observed a 13% lower affinity. The possibility that these phosphates directly affect the oxygen affinity by binding to the P2-glycerate site on hemoglobin
seems less likely based on our finding that the extra NTP compounds exist in the Mg2+-bound form (Fig. 1 and Table 1) and
on the demonstration by Bunn et al. (6) that MgATP has no effect
on the oxygen affinity of hemoglobin. Finally, although standard blood pH is usually taken as 7.4, acidosis caused by exercise or other reasons may have larger effects on the oxygen
affinity and metabolism of PND blood because of the larger pH
gradient across the erythrocyte membrane consequent to elevations in pyrimidine phosphates.
In summary, we have shown that the fixed pH gradient across
the erythrocyte membrane of PND erythrocytes is very large.
It very probably explains the lower oxygen affinity of the cell
and its abnormal glycolysis. Other consequences of the lower
intracellular pH and altered metabolic state to cell survival remain to be established.
We thank Judy Williams for manuscript preparation, John Friel for
preparation of figures, and Dr. Stuart Staley for use of the 360-MHz
NMR facility in Lincoln, NB. This work was supported by research
funds from the Cardiovascular Center of the University of Nebraska
Medical Center, the Medical Research Service ofthe Veterans Administration and by U. S. Public Health Service Grant ES 01857. The study
was carried out during the tenure of an Established Investigatorship
from the American Heart Association to J. M. S. with funds contributed
in part by the Nebraska Heart Association.
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